Medicare Enrolled
Dr. Edward Sanchez, M.D.
Surgery · Shenandoah, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sanchez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sanchez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sanchez
Dr. Edward Sanchez is a surgery specialist in Shenandoah, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Sanchez performed 5,564 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sanchez received a total of $10,198 from 59 pharmaceutical and/or device companies across 296 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sanchez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 1% volume in TX
$10,198 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,564
Medicare services
Top 1% in TX for surgery
Not available
Unique patients (not deduplicated)
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,600 | $0 | $3 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
825 | $2 | $16 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
674 | $89 | $368 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
546 | $34 | $166 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
468 | $7 | $97 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
195 | $63 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
152 | $110 | $565 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
130 | $170 | $684 |
| Nucleic acid test for organism quantification A laboratory test that uses nucleic acid detection to measure the amount of a specific organism present in a sample. |
126 | $42 | $222 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
86 | $292 | $2,762 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
80 | $674 | $3,366 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
58 | $99 | $470 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
42 | $50 | $296 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
42 | $34 | $123 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
42 | $34 | $182 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
42 | $34 | $153 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
42 | $34 | $153 |
| Strep A nucleic acid test, quantification A laboratory test that uses nucleic acid detection to identify and measure the amount of Group A Streptococcus bacteria. |
42 | $41 | $146 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
42 | $34 | $123 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
33 | $60 | $247 |
| Gardnerella vaginalis detection and quantification test A laboratory test that detects the presence of Gardnerella vaginalis bacteria and measures the amount present in a sample. |
31 | $41 | $146 |
| Sacral nerve stimulator electrode insertion A procedure to place an electrode array in the sacral area to deliver electrical stimulation to the nerves. |
30 | $597 | $6,475 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
24 | $6 | $277 |
| Assessment of muscle signal of pelvic nerves This procedure evaluates the electrical activity or signal of muscles innervated by the pelvic nerves. It is used to assess the functional status of these nerves and the muscles they control. |
24 | $108 | $747 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
23 | $153 | $522 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
22 | $305 | $1,205 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
16 | $239 | $889 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $77 | $372 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
16 | $17 | $68 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
15 | $988 | $4,403 |
| Insertion of peripheral or gastric neurostimulator generator A surgical procedure to implant the pulse generator device for a neurostimulator system. The generator is placed under the skin to deliver electrical impulses to nerves or the stomach. |
14 | $63 | $1,176 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
14 | $19 | $61 |
| Electronic analysis of implanted neurostimulator with complex programming This procedure involves the electronic evaluation of an implanted neurostimulator generator. It includes complex programming of spinal cord or peripheral nerve stimulators. |
14 | $32 | $221 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
13 | $330 | $1,370 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
13 | $0 | $36 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
12 | $173 | $1,067 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.5% high complexity
39.4% medium
60.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,198
Total received (2018-2024)
Avg $1,457/year across 7 years
Top 27% in TX for surgery
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
296
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,909
2023
$3,073
2022
$1,906
2021
$753
2020
$156
2019
$1,494
2018
$907
Payments by company (2024)
BIOTISSUE HOLDINGS INC.
$295
Axonics, Inc.
$234
Boston Scientific Corporation
$220
Endo USA, Inc.
$161
Medtronic, Inc.
$147
Myriad Genetic Laboratories, Inc.
$141
ABBVIE INC.
$115
Sumitomo Pharma America, Inc.
$102
PROCEPT BioRobotics Corporation
$101
Antares Pharma, Inc.
$71
ACCORD HEALTHCARE, INC.
$70
180 Medical, Inc.
$53
Astellas Pharma US Inc
$43
Novartis Pharmaceuticals Corporation
$26
Ferring Pharmaceuticals Inc.
$24
COLOPLAST CORP
$23
Endo Pharmaceuticals Inc.
$22
PFIZER INC.
$21
Cook Medical LLC
$21
Tolmar, Inc.
$18
Top 3 companies account for 39.2% of 2024 payments
All-time payments by company (2018-2024) ›
Axonics, Inc.
$1,563
Boston Scientific Corporation
$1,265
Myriad Genetic Laboratories, Inc.
$877
Coloplast Corp
$496
Cook Medical LLC
$441
Olympus America Inc.
$337
Janssen Biotech, Inc.
$337
BIOTISSUE HOLDINGS INC.
$295
BOSTON SCIENTIFIC CORPORATION
$289
ACCORD HEALTHCARE, INC.
$231
Endo Pharmaceuticals Inc.
$226
Teleflex LLC
$224
Sumitomo Pharma America, Inc.
$218
Antares Pharma, Inc.
$202
ABBVIE INC.
$178
Medtronic, Inc.
$176
PFIZER INC.
$171
Endo USA, Inc.
$161
UROVANT SCIENCES INC
$160
Palette Life Sciences, Inc.
$158
Agiliti Surgical, Inc.
$149
AbbVie Inc.
$138
Astellas Pharma US Inc
$133
Progenics Pharmaceuticals, Inc.
$132
Janssen Pharmaceuticals, Inc
$128
PROCEPT BioRobotics Corporation
$126
Laborie Medical Technologies Corp.
$124
180 Medical, Inc.
$114
Merck Sharp & Dohme Corporation
$94
GlaxoSmithKline, LLC.
$89
ConvaTec Inc.
$84
AstraZeneca Pharmaceuticals LP
$69
Abbott Laboratories
$64
ROCHESTER MEDICAL CORPORATION
$55
Bayer Healthcare Pharmaceuticals Inc.
$53
Shire North American Group Inc
$46
Tolmar, Inc.
$45
SANOFI PASTEUR INC.
$44
C. R. Bard, Inc. & Subsidiaries
$39
KARL STORZ Endoscopy-America
$38
Telix Pharmaceuticals
$38
Clarus Therapeutics Inc.
$35
Bard Peripheral Vascular, Inc.
$34
Blue Earth Diagnostics Limited
$28
Myovant Sciences Inc.
$26
Novartis Pharmaceuticals Corporation
$26
Ferring Pharmaceuticals Inc.
$24
Supernus Pharmaceuticals, Inc.
$23
COLOPLAST CORP
$23
Celgene Corporation
$23
Novo Nordisk Inc
$22
Amgen Inc.
$21
UroGen Pharma, Inc.
$18
Corcept Therapeutics
$18
TOLMAR Pharmaceuticals, Inc.
$17
Allergan, Inc.
$15
Calyxo, Inc.
$13
Allergan Inc.
$13
EDAP TECHNOMED INC
$11
Top 3 companies account for 36.3% of all-time payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Altis · Axonics · Axonics r-SNM System · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACAnalysis · BRACAnalysis CDx · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CATHETER · CLINICAL TRIAL PRODUCT · COOK MEDICAL NCIRCLE · COOK MEDICAL STENTS · COOK MEDICAL WIRE GUIDES · CVAC ASPIRATION SYSTEM · Cook Medical Urology · ELIGARD · ERLEADA · FARXIGA · FLUZONE HIGH-DOSE · FreeStyle Libre blood glucose Flash Monitoring System · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL BPH · GENERAL FEMALE SUI · GENERAL KIDNEY STONE DISEASE · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENTLECATH · GENTLECATH GLIDE · GREENLIGHT · ILLUCCIX · IMAGE1 X-LINK · INTERSTIM · JANUVIA · JATENZO · JELMYTO · Korlym · LithoVue · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · Olympus Laser Devices · Ozempic · PLUVICTO · POSLUMA · PROCLAIM · PROLARIS · PYLARIFY · Porges Coloplast · Prolaris · RESONATE EL ICD VR · Repatha · Rezum Generator · SIMPONI ARIA · STEGLATRO · STELARA · SpaceOAR VUE System - 10mL · SpeediCath · TACTRA · TLANDO · TORNADO · TRELEGY ELLIPTA · UGN Laser Capital · UROLIFT · UroLift 2 System · UroLift System · WATCHMAN Access System · XARELTO · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System · n.a.
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Surgerists in nearby ZIP areas
105
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST THE WOODLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sanchez is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sanchez experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Sanchez performed 1,600 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sanchez receive payments from pharmaceutical companies?
Yes. Dr. Sanchez received a total of $10,198 from 59 companies across 296 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sanchez's costs compare to other surgerists in Shenandoah?
Dr. Sanchez's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sanchez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Surgerists in Shenandoah
Browse surgerists in Shenandoah ranked by procedure volume and transparency data.
Highest volume
Top Surgerists in TX
Surgerists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Surgerists in TX
Which TX surgerists receive the most from drug and device companies.
By company
Axonics, Inc. Payments to Doctors
See all physicians who received payments from Axonics, Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology